Cynthia Hudson

Cynthia Hudson is a prominent figure in the fertility industry, currently serving as a Founding Partner at both NOVA Genomics and Perch Fertility, as well as the President of the New England Fertility Society. With extensive experience, Cynthia holds roles as a Strategic Advisor at Fertilidad Integral, Sama Fertility, and LEVY Health. At TMRW Life Sciences, a pioneering company in fertility cryostorage, Cynthia contributes as VP of Clinical Strategy and Executive Director of Embryology Strategy and Operations. Cynthia also serves on the Scientific Advisory Board for Hamilton Thorne, Inc. and is the Founder/CEO of Cellavita LLC, which offers advisory and management services. Additionally, Cynthia has provided consultancy for DxNow, Inc. and holds a Master of Science in Clinical Embryology from the University of Leeds, along with a Bachelor of Science from Springfield College.